{"product_id":"tirzepatide-10mg","title":"Tirzepatide 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Tirzepatide 10mg in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout Tirzepatide\u003c\/h2\u003e\n\u003cp\u003eTirzepatide (research code LY-3298176) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIP-R) and the glucagon-like peptide-1 receptor (GLP-1R). Optic Labs supplies tirzepatide as a high-purity lyophilised powder in 10mg vials, packaged for in vitro and preclinical laboratory research.\u003c\/p\u003e\n\n\u003cp\u003eEach batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eTirzepatide is one of the most extensively studied compounds in the recent metabolic research literature, with published Phase 3 clinical trial data examining glycaemic control and body composition in human study populations. Optic Labs supplies tirzepatide for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Tirzepatide (LY-3298176)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 2023788-19-2\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e225\u003c\/sub\u003eH\u003csub\u003e348\u003c\/sub\u003eN\u003csub\u003e48\u003c\/sub\u003eO\u003csub\u003e68\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~4813.5 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism (research context):\u003c\/strong\u003e Dual agonist — GIP-R + GLP-1R\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eTirzepatide was developed as a dual incretin agonist, combining GIP and GLP-1 receptor activity in a single molecule. Published preclinical and clinical research has examined tirzepatide in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGIP and GLP-1 receptor binding, signalling and downstream pathways\u003c\/li\u003e\n\u003cli\u003eGlycaemic control and insulin sensitivity in type 2 diabetes research models\u003c\/li\u003e\n\u003cli\u003eBody composition and adiposity in animal models and clinical study populations\u003c\/li\u003e\n\u003cli\u003eHepatic lipid metabolism and NAFLD\/MASH research models\u003c\/li\u003e\n\u003cli\u003eGastric emptying and appetite-regulation research\u003c\/li\u003e\n\u003cli\u003ePhase 1, 2 and 3 clinical pharmacokinetic, glycaemic and weight-change studies (SURPASS and SURMOUNT programmes)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eTirzepatide is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A 10mg vial reconstituted in 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a working concentration of 5mg\/mL; 1mL yields 10mg\/mL.\u003c\/p\u003e\n\n\u003cp\u003eExact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C and protected from light.\u003c\/p\u003e\n\n\u003ch2\u003eComparisons and related research compounds\u003c\/h2\u003e\n\u003cp\u003eTirzepatide sits within the broader class of incretin and metabolic peptides. Researchers may also be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — triple agonist (GLP-1 + GIP + glucagon), successor research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — fragment growth-hormone analogue, fat-loss research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — GHRH analogue, lipolysis research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — growth-hormone-releasing research peptide combination\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibitor, metabolic research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs tirzepatide legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eTirzepatide has been registered with the Therapeutic Goods Administration (TGA) as a prescription-only therapeutic product in Australia under separate brand registrations. Optic Labs does not supply tirzepatide as a therapeutic, prescription or compounded product. Optic Labs supplies tirzepatide strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is tirzepatide?\u003c\/h3\u003e\n\u003cp\u003eTirzepatide (LY-3298176) is a synthetic 39-amino-acid peptide developed as a dual agonist of the GIP and GLP-1 receptors. In published research it has been investigated for its effects on glycaemic control, body composition, hepatic lipid metabolism and gastric emptying.\u003c\/p\u003e\n\n\u003ch3\u003eHow does tirzepatide differ from semaglutide and retatrutide?\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 + GIP agonist. \u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e adds a third receptor target — the glucagon receptor — making it a triple agonist. The published research literature has examined each compound across its own clinical programme, and the receptor profiles differ in mechanism rather than being directly interchangeable.\u003c\/p\u003e\n\n\u003ch3\u003eHow is tirzepatide supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies tirzepatide as a lyophilised powder in a glass research vial at the 10mg size. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a tirzepatide 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the working concentration required by the research protocol. As a starting reference: 10mg in 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields 5mg\/mL; 10mg in 1mL yields 10mg\/mL. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted tirzepatide be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 30 days. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53494794256568,"sku":null,"price":159.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/hf_20260522_084941_32ee276b-124f-4167-873c-b7195697b3e4.png?v=1779439938","url":"https:\/\/opticlabsau.com\/products\/tirzepatide-10mg","provider":"Optic Labs","version":"1.0","type":"link"}